Know Cancer

or
forgot password

Challenging the Paradigm in Pain Relief for Advanced Breast and Prostate Cancer Patients With Vertebral Metastasis: Vertebral Augmentation With Cement Plus Radiotherapy Versus Radiotherapy. A Randomized, Prospective, Double Blind Pilot Study


Phase 3
35 Years
75 Years
Open (Enrolling)
Both
Breast Cancer, Prostate Cancer, Vertebral Metastasis, Pain

Thank you

Trial Information

Challenging the Paradigm in Pain Relief for Advanced Breast and Prostate Cancer Patients With Vertebral Metastasis: Vertebral Augmentation With Cement Plus Radiotherapy Versus Radiotherapy. A Randomized, Prospective, Double Blind Pilot Study


Included patients presenting with spinal metastasis secondary to breast or prostate cancer
are randomized to two groups, intervention and control. Both groups receive standard
radiotherapy, which is currently the gold standard of care for such patients. The
intervention group will also receive a vertebroplasty [single or multiple level(s)], while
the control group will receive a simulated vertebroplasty, where local anesthesia and gentle
hand manipulation will be used but the vertebra will not be accessed. The primary outcome
is pain relief, though other factors such as quality of life and pain medications will also
be evaluated.

There will be an interim analysis after half of the patients have been treated with a
follow-up of 3 months. In the analysis, comparisons will be made between the two groups and
each patient's individual progress will also be analyzed.


Inclusion Criteria:



- Between 35 and 75 years old

- Biopsy-proven breast cancer (BC) or prostate cancer (PC)

- Radiographic evidence of spine metastases from the BC or PC in the lumbar and/or
mid-low thoracic spine

- Microfractures or compression fractures up to 40% of the original height of the
vertebral body in an MRI [magnetic resonance imaging] (reported by an independent
radiologist)

- Incidental back pain (Verbal Analog Scale > 5/10) felt to be related to those
metastases

Exclusion Criteria:

- Spinal cord compression

- Massive rupture of the posterior wall of the vertebral body (according to blinded
radiological report)

- Coagulopathy (International Normalized Ratio [INR] > 1.5, platelets < 80,000)

- Inability to communicate in English, French or Spanish

- Previous radiotherapy to the spine in the area presently affected

- Mental cognitive impairment

- Vertebral metastasis without fracture in the MRI

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Outcome Measure:

pain relief; score on pain questionnaire

Outcome Time Frame:

at baseline, 1 week, 2 weeks, 4 weeks, 3 months, 6 months, 1 year after

Principal Investigator

Juan F Asenjo, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Montreal General Hospital

Authority:

Canada: Ethics Review Committee

Study ID:

GEN#05-015

NCT ID:

NCT00294151

Start Date:

September 2005

Completion Date:

Related Keywords:

  • Breast Cancer
  • Prostate Cancer
  • Vertebral Metastasis
  • Pain
  • breast cancer
  • prostate cancer
  • vertebral metastasis
  • vertebroplasty
  • vertebral metastasis from breast cancer
  • vertebral metastasis from prostate cancer
  • Breast Neoplasms
  • Neoplasm Metastasis
  • Neoplasms, Second Primary
  • Prostatic Neoplasms

Name

Location